Volitionrx (VNRX) Depreciation & Amortization (CF) (2011 - 2025)

Volitionrx has reported Depreciation & Amortization (CF) for 15 years, with the latest figure at $230824.0 in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 21.92% year-over-year to $230824.0; the trailing twelve-month figure through Dec 2025 stood at $983706.0 (down 11.63% YoY), and the FY2025 full-year result was $983706.0, down 11.63% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $230824.0, down from $248253.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $296587.0 in Q4 2023, with the low at $224310.0 in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $256543.8 across 5 years, with a median of $250454.5 in 2022.
• Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) soared 42.7% — and 2025, when it dropped 21.92%.
• Volitionrx's Depreciation & Amortization (CF) stood at $236847.0 in 2021, then rose by 5.12% to $248968.0 in 2022, then gained by 19.13% to $296587.0 in 2023, then declined by 0.32% to $295642.0 in 2024, then retreated by 21.92% to $230824.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $230824.0 (Q4 2025), $248253.0 (Q3 2025), and $252688.0 (Q2 2025), per Business Quant data.